Moderna and Pfizer will soon launch trials to evaluate the long-term risk of myocarditis, or inflammation of the heart muscle, with their COVID-19 vaccines, NBC News reported Nov. 12.
Read the full post on Becker's Hospital Review - Healthcare News
